OCS Liver Perfusion (OLP) Post-Approval Registry

Status Active, not recruiting

Clinical Trial Summary

The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.

Clinical Trial Description

OLP Registry is a multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below. ;

Study Design

Related Conditions & MeSH terms

Liver Transplant

Clinical Trial Details

NCT number	NCT05074160
Study type	Observational [Patient Registry]
Source	TransMedics
Contact
Status	Active, not recruiting
Phase
Start date	October 14, 2021
Completion date	June 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02798861` - Controlled Attenuation Parameter (CAP) in Liver Allografts
Completed	`NCT03527238` - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine	Phase 2
Completed	`NCT01696331` - Text Messaging for Adherence in Adolescent Liver Transplant Recipients	N/A
Recruiting	`NCT05051605` - Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Recruiting	`NCT05940857` - Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
Completed	`NCT01598987` - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.	Phase 3
Completed	`NCT05087550` - Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Recruiting	`NCT04836923` - LIFT Intervention in Liver Transplant Candidates	N/A
Not yet recruiting	`NCT03666689` - Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Not yet recruiting	`NCT06088758` - Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool	N/A
Terminated	`NCT01230502` - Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation	N/A
Completed	`NCT00171509` - Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients	Phase 4
Not yet recruiting	`NCT06254248` - Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma	Phase 2
Recruiting	`NCT06075745` - Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates	Phase 2
Not yet recruiting	`NCT06280950` - Expanding Liver Transplant Immunosuppression Minimization Via Everolimus	Phase 2
Completed	`NCT02057484` - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Active, not recruiting	`NCT03577431` - Liver Transplantation With Tregs at MGH	Phase 1/Phase 2
Recruiting	`NCT06342557` - Transitional ePRO Diary Liver
Not yet recruiting	`NCT04265157` - Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant
Recruiting	`NCT02863250` - Australian and New Zealand Massive Transfusion Registry